Dapivirine (TMC120)Nonnucleoside reverse transcriptase inhibitor CAS# 244767-67-7 |
- Limonin
Catalog No.:BCN6057
CAS No.:1180-71-8
- Fosamprenavir Calcium Salt
Catalog No.:BCC1581
CAS No.:226700-81-8
- HIV-1 integrase inhibitor
Catalog No.:BCC1618
CAS No.:544467-07-4
- BMS-626529
Catalog No.:BCC1427
CAS No.:701213-36-7
- HIV-1 integrase inhibitor 2
Catalog No.:BCC1619
CAS No.:957890-42-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 244767-67-7 | SDF | Download SDF |
PubChem ID | 214347 | Appearance | Powder |
Formula | C20H19N5 | M.Wt | 329.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | TMC120; R147681 | ||
Solubility | DMSO : ≥ 47 mg/mL (142.68 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile | ||
SMILES | CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C | ||
Standard InChIKey | ILAYIAGXTHKHNT-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Dapivirine (TMC120) is a non-nucleoside inhibitor of HIV reverse transcriptase with an IC50 vaule of 24 nM. | |||||
Targets | HIV reverse transcriptase | |||||
IC50 | 24 nM |
Dapivirine (TMC120) Dilution Calculator
Dapivirine (TMC120) Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.0358 mL | 15.1791 mL | 30.3582 mL | 60.7165 mL | 75.8956 mL |
5 mM | 0.6072 mL | 3.0358 mL | 6.0716 mL | 12.1433 mL | 15.1791 mL |
10 mM | 0.3036 mL | 1.5179 mL | 3.0358 mL | 6.0716 mL | 7.5896 mL |
50 mM | 0.0607 mL | 0.3036 mL | 0.6072 mL | 1.2143 mL | 1.5179 mL |
100 mM | 0.0304 mL | 0.1518 mL | 0.3036 mL | 0.6072 mL | 0.759 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Dapivirine (DPV) is a nonnucleoside reverse transcriptase inhibitor with a favorable safety profile following vaginal application.
- Pseudoakuammigine
Catalog No.:BCN4812
CAS No.:2447-70-3
- Sulfadoxine
Catalog No.:BCC4726
CAS No.:2447-57-6
- Sanguinarine
Catalog No.:BCN5102
CAS No.:2447-54-3
- 4-Chlorodehydromethyltestosterone
Catalog No.:BCC8704
CAS No.:2446-23-3
- Daphnetin dimethyl ether
Catalog No.:BCN2735
CAS No.:2445-80-9
- Nonivamide
Catalog No.:BCN2325
CAS No.:2444-46-4
- 3,5,7,15-Tetraacetoxy-9-nicotinoyloxy-6(17),11-jatrophadien-14-one
Catalog No.:BCN6592
CAS No.:244277-75-6
- LFM-A13
Catalog No.:BCC6472
CAS No.:244240-24-2
- JTC-801
Catalog No.:BCC3800
CAS No.:244218-51-7
- Celaphanol A
Catalog No.:BCN5101
CAS No.:244204-40-8
- Pulchinenoside E2
Catalog No.:BCN8186
CAS No.:244202-36-6
- L-748,337
Catalog No.:BCC7475
CAS No.:244192-94-7
- Z-D-Phe-OH
Catalog No.:BCC2755
CAS No.:2448-45-5
- Bryonolic acid
Catalog No.:BCN5103
CAS No.:24480-45-3
- Isochlorogenic acid A
Catalog No.:BCN5908
CAS No.:2450-53-5
- Acetylshikonin
Catalog No.:BCN2665
CAS No.:24502-78-1
- Dimethylacrylshikonin
Catalog No.:BCN2310
CAS No.:23444-70-4
- 19-Oxocinobufagin
Catalog No.:BCN8229
CAS No.:24512-59-2
- 19-Oxocinobufotalin
Catalog No.:BCN8233
CAS No.:24512-60-5
- Gardenoside
Catalog No.:BCN2383
CAS No.:24512-62-7
- Geniposide
Catalog No.:BCN5104
CAS No.:24512-63-8
- Monomethyl kolavate
Catalog No.:BCN5105
CAS No.:24513-41-5
- 3,21-Dihydroxy-14-serraten-16-one
Catalog No.:BCN5106
CAS No.:24513-51-7
- 21-Episerratriol
Catalog No.:BCN5107
CAS No.:24513-57-3
Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.[Pubmed:19388819]
AIDS Res Hum Retroviruses. 2009 May;25(5):483-8.
Vaginal delivery of 200 mg or 25 mg dapivirine from intravaginal rings (IVRs) was evaluated over a 7-day period in two phase 1 safety trials (IPM001 and IPM008, respectively) in a total of 25 healthy women 19 to 46 years of age. The IVR was generally safe and well tolerated with similar adverse events observed in the placebo and dapivirine groups. Across both studies, dapivirine concentrations in vaginal fluids measured at the introitus, cervix, and ring area were within the mean range of 0.7-7.1 microg/ml. Mean dapivirine concentrations in vaginal and cervical tissues on day 7 were 0.3-0.7 microg/g in IPM001 and 1.5-3.5 microg/g in IPM008. Mean plasma concentrations of dapivirine were <50 pg/ml. Dapivirine from both IVRs was successfully distributed throughout the lower genital tract at concentrations >1000x the EC(50) against wild-type HIV-1 (LAI) in MT4 cells suggesting that IVR delivery of microbicides is a viable option meriting further study.